Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
MapLight Therapeutics, Inc. ( (MPLT) ) has issued an announcement.
MapLight Therapeutics, Inc. successfully closed its initial public offering (IPO) on October 28, 2025, issuing 14,750,000 shares of common stock at $17.00 per share, with underwriters exercising an option to purchase an additional 2,212,500 shares. Concurrently, the company completed a private placement with Goldman Sachs affiliates, raising gross proceeds of $296.3 million from both the IPO and private placement, which will enhance its financial position and market presence.
More about MapLight Therapeutics, Inc.
For detailed information about MPLT stock, go to TipRanks’ Stock Analysis page.